Clinical impact of whole body FDG-PET for recurrent biliary cancer: A multicenter study

Annals of Nuclear Medicine

Volumn 23, Issue 8, 2009, Pages 709-715

  Kitajima, Kazuhiro ^a   Murakami, Koji ^a   Kanegae, Kakuko ^b   Tamaki, Nagara ^b   Kaneta, Tomohiro ^c   Fukuda, Hiroshi ^d   Nakajima, Kotaro ^e   Fujii, Hirofumi ^f   Tateishi, Ukihide ^g   Kubota, Kazuo ^h   Suga, Tsuyoshi ⁱ   Nakamoto, Yuji ⁱ  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

^e Hitachi   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^g YOKOHAMA CITY UNIVERSITY   (Japan)

^h NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

ⁱ KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

18F FDG; Biliary cancer; PET; PET CT; Recurrence

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILE DUCT CARCINOMA; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; GALLBLADDER CANCER; HUMAN; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; WHOLE BODY RADIATION;

AGED; AGED, 80 AND OVER; BILIARY TRACT NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 70350137419     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-009-0297-6     Document Type: Article

References (16)

1. T Beyer DW Townsend T Brun PE Kinahan M Charron R Roddy, et al. 2000 A combined PET/CT scanner for clinical oncology J Nucl Med 41 1369 79 1:STN:280:DC%2BD3cvitFCguw%3D%3D 10945530
2. K Kitajima K Murakami E Yamasaki S Hagiwara I Fukasawa N Inaba, et al. 2008 Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer Ann Nucl Med 22 103 9 10.1007/s12149-007-0087-y 18311534 (Pubitemid 351328965)
3. K Kitajima K Murakami E Yamasaki Y Domeki Y Kaji K Sugimura 2008 Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer Eur Radiol 18 2040 7 10.1007/s00330-008-0979-9 18425518
4. M Nogami Y Nakamoto S Sakamoto K Fukushima T Okada T Saga, et al. 2007 Diagnostic performance of CT, PET, side-by-side, and fused image interpretations for restaging of non-Hodgkin lymphoma Ann Nucl Med 21 189 96 10.1007/s12149-007-0015-1 17581717 (Pubitemid 47387444)
5. H Petrowsky P Wildbrett DB Husarik TF Hany S Tam W Jochum, et al. 2006 Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma J Hepatol 45 43 50 10.1016/j.jhep.2006.03.009 16690156 (Pubitemid 43850623)
6. 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging Am J Gastroenterol 103 1145 51 10.1111/j.1572-0241.2007.01710.x 18177454 (Pubitemid 351677961)
7. CM Moon S Bang JB Chung SW Park SY Song M Yun, et al. 2008 Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas J Gastroenterol Hepatol 23 759 65 10.1111/j.1440-1746.2007.05173.x 17931372
8. 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT, and histopathology Eur Radiol 18 2841 2847 10.1007/s00330-008-1062-2 18509655
9. CD Anderson MH Rice CW Pinson WC Chapman RS Chari D Delbeke 2004 Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma J Gastrointest Surg 8 90 7 10.1016/j.gassur.2003.10.003 14746840 (Pubitemid 38117282)
10. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer J Am Coll Surg 206 57 65 10.1016/j.jamcollsurg.2007.07.002 18155569 (Pubitemid 350267250)
11. A Chikamoto T Tsuji H Takamori K Kanemitsu H Uozumi Y Yamashita, et al. 2006 The diagnostic efficacy of FDG-PET in the local recurrence of hilar bile duct cancer J Hepatobiliary Pancreat Surg 13 403 8 10.1007/s00534-005-1086-9 17013714 (Pubitemid 44480242)
12. H Jadvar RW Henderson PS Conti 2007 [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma J Comput Assist Tomogr 31 223 8 10.1097/01.rct.0000237811.88251.d7 17414758 (Pubitemid 46573360)
13. K Kitajima K Murakami E Yamasaki I Fukasawa N Inaba Y Kaji, et al. 2008 Accuracy of FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer AJR Am J Roentgenol 190 1652 8 10.2214/AJR.07.3372 18492920 (Pubitemid 351798544)
14. S Bipat MS van Leeuwen EFI Comans ME Piji PM Bossuyt AH Zwinderman, et al. 2005 Colorectal liver metastases: CT, MR imaging, and PET for diagnosis. Meta-analysis Radiology 237 123 31 10.1148/radiol.2371042060 16100087 (Pubitemid 41346155)
15. E Squillaci G Manenti S Mancino C Ciccio F Calabria R Donieli, et al. 2008 Staging of colon cancer: whole-body MRI vs. whole body PET/CT-initial clinical experience Abdom Imaging 33 676 88 10.1007/s00261-007-9347-5 18373114
16. R Hammerstingl A Huppertz J Breuer T Balzer A Blakeborough R Carter, et al. 2008 Diagnostic efficacy of gadoxetic acid (primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions Eur Radiol 18 457 67 10.1007/s00330-007-0716-9 18058107 (Pubitemid 351248177)